Back to top

Axsome Targets Smoking Cessation With New Phase 3 AXS-05 Trial

Axsome Therapeutics Inc. ($AXSM) announced an update on their ongoing clinical study. The study titled “A Randomized, Double-Blind, Placebo and Act...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Axsome Therapeutics, Inc. (AXSM)